MetaCap

Benitec Biopharma (BNTC) vs Relmada Therapeutics (RLMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.

Summary

Relmada Therapeutics (RLMD) has outperformed Benitec Biopharma (BNTC) over the past year, gaining 63.3% versus a loss of 34.8%. Over five years, BNTC leads with a -85.3% price change compared with -86.2% for RLMD. Relmada Therapeutics is the larger company by market cap ($346.7 million vs $313.6 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BNTC-34.76%RLMD+63.32%
+311%+130%-51%
Oct 7, 20251 yearOct 7, 2026
BNTC-85.47%RLMD-87.58%
+48%-29%-106%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BNTC versus RLMD key metrics
MetricBNTCRLMD
Share price$8.99$3.25
Market cap$313.60M$346.68M
1-day change-0.11%-0.91%
YTD return-33.26%-32.71%
1-year return-34.76%+63.32%
5-year return-85.27%-86.25%
EPS (TTM)$-0.98$-0.91
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$16.76$8.00
52-week low$8.52$1.80
Distance from 52-week high-46.36%-59.38%
Average volume150.34K1.34M
Shares outstanding34.88M106.67M
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • RLMD has outperformed BNTC by 98.1 percentage points over the past year.

BNTC vs RLMD FAQ

Which is bigger, Benitec Biopharma or Relmada Therapeutics?

Relmada Therapeutics (RLMD) is larger, with a market capitalization of $346.68M compared with $313.60M for Benitec Biopharma (BNTC).

Which stock has performed better over the past year, BNTC or RLMD?

RLMD returned +63.32% over the past 12 months, compared with -34.76% for BNTC (price return, excluding dividends). Past performance does not predict future results.

Are Benitec Biopharma and Relmada Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons